Unraveling Biogen’s Dilemma: Can AI and New Treatments Revive Its Fortunes?
Biogen Inc. faces significant challenges in the pharmaceutical industry, focusing on neurological diseases for growth opportunities despite financial pressures. Recent resilience in core operations
